Efficacy of trelagliptin for glucose fluctuation, oxidative stress and inflammation in patients with type 2 diabetes mellitus.
Phase of Trial: Phase II
Latest Information Update: 25 Sep 2016
At a glance
- Drugs Trelagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 25 Sep 2016 Status changed from active, no longer recruiting to completed according to the results presented at the 76th Annual Scientific Sessions of the American Diabetes Association.
- 15 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 27 Aug 2015 New trial record